Cargando…

Enhancing Anticancer Efficacy of Chemotherapeutics Using Targeting Ligand-Functionalized Synthetic Antigen Receptor-Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) have been studied for their potential in facilitating tumor-targeted delivery of chemotherapeutics due to their tumor-homing characteristics. We hypothesized that targeting effectiveness of MSCs can be further enhanced by incorporating tumor-targeting ligands on MSC sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nethi, Susheel Kumar, Li, Xiaolei, Bhatnagar, Shubhmita, Prabha, Swayam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304812/ https://www.ncbi.nlm.nih.gov/pubmed/37376189 http://dx.doi.org/10.3390/pharmaceutics15061742

Ejemplares similares

Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing
por: Prabha, Swayam, et al.
Publicado: (2023)

Pharmacokinetic—Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
por: Cheng, Shen, et al.
Publicado: (2021)

Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer
por: Layek, Buddhadev, et al.
Publicado: (2020)

Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

Improving Payload Capacity and Anti-Tumor Efficacy of Mesenchymal Stem Cells Using TAT Peptide Functionalized Polymeric Nanoparticles
por: Moku, Gopikrishna, et al.
Publicado: (2019)

Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019)

Zein Microneedles for Transcutaneous Vaccine Delivery: Fabrication, Characterization, and in Vivo Evaluation Using Ovalbumin as the Model Antigen
por: Bhatnagar, Shubhmita, et al.
Publicado: (2017)

Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis
por: Long, Jian-Ting, et al.
Publicado: (2014)

Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs
por: Stathopoulou, Athanasia, et al.
Publicado: (2012)

Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents
por: Bao, Jiaolin, et al.
Publicado: (2015)

Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
por: Zlotos, Darius P., et al.
Publicado: (2022)

Apoptosis of CD19(+) chimeric antigen receptor T cells after treatment with chemotherapeutic agents
por: Yi, Wenfang, et al.
Publicado: (2018)

Composite Hydrogels with Included Solid-State Nanoparticles Bearing Anticancer Chemotherapeutics
por: Zhivkov, Alexandar M., et al.
Publicado: (2023)

In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
por: Frik, Malgorzata, et al.
Publicado: (2014)

Chemotherapeutic Stress Influences Epithelial–Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer
por: Li, Xiao, et al.
Publicado: (2020)

Activation of IP(3) receptors by synthetic bisphosphate ligands
por: Sureshan, Kana M., et al.
Publicado: (2009)

Biosynthesis of Metal Nanoparticles via Microbial Enzymes: A Mechanistic Approach
por: Ovais, Muhammad, et al.
Publicado: (2018)

Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
por: Georgiadis, Markos-Orestis, et al.
Publicado: (2017)

Evaluation of Transition Metal Complexes of Benzimidazole-Derived Scaffold as Promising Anticancer Chemotherapeutics
por: Hussain, Afzal, et al.
Publicado: (2018)

Synthetic Flavanones Augment the Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Szliszka, Ewelina, et al.
Publicado: (2012)

Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics
por: Parashar, Krishan, et al.
Publicado: (2019)

Is There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?
por: Quirk, Kendel, et al.
Publicado: (2017)

Comparison of Different Clinical Chemotherapeutical Agents’ Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells
por: Vajda, Flóra, et al.
Publicado: (2022)

Computational Study of Synthetic Agonist Ligands of Ionotropic Glutamate Receptors
por: Wolter, Tino, et al.
Publicado: (2013)

In vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles
por: Li, Yingqi, et al.
Publicado: (2014)

A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
por: Gidwani, Bina, et al.
Publicado: (2015)

Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review
por: Eitsuka, Takahiro, et al.
Publicado: (2016)

Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance
por: Xuan, Xiuyun, et al.
Publicado: (2021)

Inhibition of Tumor Angiogenesis and Growth by Nanoparticle-Mediated p53 Gene Therapy in Mice
por: Prabha, Swayam, et al.
Publicado: (2012)

Local bacteria affect the efficacy of chemotherapeutic drugs
por: Lehouritis, Panos, et al.
Publicado: (2015)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
por: Yang, Ping-Lian, et al.
Publicado: (2020)

Anticancer Activity of Natural and Synthetic Chalcones
por: Constantinescu, Teodora, et al.
Publicado: (2021)

Mesenchymal stem cells show functional defect and decreased anti-cancer effect after exposure to chemotherapeutic drugs
por: Somaiah, Chinnapaka, et al.
Publicado: (2018)

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
por: Skelhorne-Gross, Graham, et al.
Publicado: (2012)

Correction: Computational Study of Synthetic Agonist Ligands of Ionotropic Glutamate Receptors
por: Wolter, Tino, et al.
Publicado: (2014)

Synthetic cytokine receptors transmit biological signals using artificial ligands
por: Engelowski, Erika, et al.
Publicado: (2018)

Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ
por: Shang, Jinsai, et al.
Publicado: (2018)

Engineering of an enhanced synthetic Notch receptor by reducing ligand-independent activation
por: Yang, Zi-jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hqdae5tf4qaqrudjbhrt4sa6ci